August 20, 2014 12:58 AM ET

Biotechnology

Company Overview of VIRxSYS Corporation

Company Overview

VIRxSYS Corporation, a biotechnology company, focuses on the development of gene and vaccine therapies for the treatment of HIV/AIDS, cancer, and genetic diseases in the United States. The company was incorporated in 1998 and is based in Gaithersburg, Maryland.

200 Perry Parkway

Suite 1A

Gaithersburg, MD 20877

United States

Founded in 1998

Phone:

301-987-0480

Fax:

301-987-0489

Key Executives for VIRxSYS Corporation

Co-Founder and Director
Age: 67
Co-Founder and Director
Chief Financial Officer
Vice President of Clinical Affairs
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Apellis Pharmaceuticals, Inc. United States
PaxVax, Inc. United States
Lypro Biosciences, Inc. United States
Phage Pharmaceuticals, Inc. United States
TVAX Biomedical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIRxSYS Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.